Medial septal beta-amyloid 1-40 injections alter septo-hippocampal anatomy and function by Colom, Luis V. et al.
University of Texas Rio Grande Valley 
ScholarWorks @ UTRGV 
Health and Biomedical Sciences Faculty 
Publications and Presentations College of Health Professions 
1-2010 
Medial septal beta-amyloid 1-40 injections alter septo-
hippocampal anatomy and function 
Luis V. Colom 
The University of Texas Rio Grande Valley 
María Teresa Castañeda Licón 




See next page for additional authors 
Follow this and additional works at: https://scholarworks.utrgv.edu/hbs_fac 
 Part of the Medicine and Health Sciences Commons 
Recommended Citation 
Colom, L. V., Castañeda, M. T., Bañuelos, C., Puras, G., García-Hernández, A., Hernandez, S., Mounsey, S., 
Benavidez, J., & Lehker, C. (2010). Medial septal beta-amyloid 1-40 injections alter septo-hippocampal 
anatomy and function. Neurobiology of aging, 31(1), 46–57. https://doi.org/10.1016/
j.neurobiolaging.2008.05.006 
This Article is brought to you for free and open access by the College of Health Professions at ScholarWorks @ 
UTRGV. It has been accepted for inclusion in Health and Biomedical Sciences Faculty Publications and 
Presentations by an authorized administrator of ScholarWorks @ UTRGV. For more information, please contact 
justin.white@utrgv.edu, william.flores01@utrgv.edu. 
Authors 
Luis V. Colom, María Teresa Castañeda Licón, C. Banuelos, Gustavo Puras, Antonio García-Hernández, 
Sofia Hernandez, Suzanne Mounsey, Joy Benavidez, and Claudia Lehker 
This article is available at ScholarWorks @ UTRGV: https://scholarworks.utrgv.edu/hbs_fac/74 
Medial septal β-amyloid 1–40 injections alter septo-hippocampal
anatomy and function
Luis V. Colom1,2,*, Maria T. Castañeda1, Cristina Bañuelos1, Gustavo Puras1, Antonio
García-Hernández1, Sofia Hernandez1, Suzanne Mounsey1, Joy Benavidez1, and Claudia
Lehker
1 Department of Biological Sciences at the University of Texas at Brownsville/Texas Southmost
College, 80 Fort Brown, Brownsville, Texas 78520 USA
2 Center for Biomedical Studies
Abstract
Degeneration of septal neurons in Alzheimer’s disease (AD) results in abnormal information
processing at cortical circuits and consequent brain dysfunction. The septum modulates the activity
of hippocampal and cortical circuits and is crucial to the initiation and occurrence of oscillatory
activities such as the hippocampal theta rhythm. Previous studies suggest that amyloid β peptide
(Aβ) accumulation may trigger degeneration in AD. This study evaluates the effects of single
injections of Aβ 1–40 into the medial septum. Immunohistochemistry revealed a decrease in septal
cholinergic (57%) and glutamatergic (53%) neurons in Aβ 1–40 treated tissue. Additionally,
glutamatergic terminals were significantly less in Aβ treated tissue. In contrast, septal GABAergic
neurons were spared. Unitary recordings from septal neurons and hippocampal field potentials
revealed an approximately 50% increase in firing rates of slow firing septal neurons during theta
rhythm and large irregular amplitude (LIA) hippocampal activities and a significantly reduced
hippocampal theta rhythm power (49%) in Aβ 1–40 treated tissue. Aβ also markedly reduced the
proportion of slow firing septal neurons correlated to the hippocampal theta rhythm by 96%. These
results confirm that Aβ alters the anatomy and physiology of the medial septum contributing to septo-
hippocampal dysfunction. The Aβ induced injury of septal cholinergic and glutamatergic networks
may contribute to an altered hippocampal theta rhythm which may underlie the memory loss typically
observed in AD patients.
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1. Introduction
Alzheimer’s disease (AD) is an age-related progressive disorder of the brain that leads to
memory loss, dementia and, ultimately death. Although AD was described a century ago, the
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molecular mechanisms underlying neuronal dysfunction and degeneration are still unclear. The
brain of an individual with AD exhibits extracellular senile plaques of aggregated amyloid-β-
peptide (Aβ) and a profound loss of basal forebrain cholinergic neurons that innervate the
hippocampus and the neocortex (Whitehouse et al, 1982; Selkoe 2000;Hardy and Selkoe,
2002). This loss of basal forebrain cholinergic neurons led to the cholinergic hypothesis of AD
which states that basal forebrain cholinergic neurons are severely affected in the course of the
disease and that the resulting cerebral cholinergic deficit leads to memory loss and other
cognitive symptoms, which are characteristic of AD (Davies and Maloney, 1976; Pearson et
al, 1983; Schliebs, 2005). Recent studies have shown an association between a decline in
learning and memory and a deficit in excitatory amino acid neurotransmission. This deficit
accompanies the impairment of the cholinergic system which modulates glutamatergic
neurotransmission by targeting the neocortical and hippocampal glutamatergic pyramidal
neurons (Francis et al., 1999). Thus, AD neurological decline may be attributed to cholinergic
hypofunction, as described in the cholinergic hypothesis, in combination with the loss of
excitatory glutamatergic function (Francis et al., 1999).
The septum and the hippocampus are heavily interconnected through the fimbria-fornix and
are functionally coupled (Bland and Colom, 1993), often referred to collectively as the septo-
hippocampal system (Colom, 2006). The septo-hippocampal projection includes well-known
cholinergic and GABAergic components (Lynch et al., 1977; Kohler et al., 1984; Bland and
Colom, 1993). Recent electrophysiological and anatomical studies have shown that a
subpopulation of septal glutamatergic neurons projects to the hippocampus (Sotty et al.,
2003; Hajszan et al., 2004; Manseau et al., 2005), constituting 23% of the septo-hippocampal
projection (Colom et al., 2005). Hence, the septo-hippocampal projection is a three
neurotransmitter pathway.
The synchronized depolarization of hippocampal neurons produces field potentials in a
frequency range of 3–12 Hz typically referred to as theta rhythm (Bland and Colom, 1993).
Several lines of evidence indicate that the septum plays a critical role in hippocampal theta
rhythm generation (Morales et al. 1971; Colom and Bland 1991; Bland and Colom, 1993; Lee
et al., 1994; Vinogradova, 1995; Bland et al., 1999). Furthermore, the occurrence of
hippocampal theta rhythm depends on the proportion of septal neurons involved in the rhythmic
process while the frequency of the theta field activity is determined by the frequency of the
rhythmical “theta” bursts in septal neurons (Bland and Colom, 1993; Vinogradova, 1995; Bland
et al., 1999). Septal lesions, in addition to blocking theta, produce severe impairments in
memory processes (Winson, 1978; Vinogradova, 1995). The hippocampal theta rhythm
appears to act as a windowing mechanism for synaptic plasticity (Huerta and Lisman, 1993).
Theta also plays a role in the neural coding of place (Winson, 1978; O’Keefe, 1993). Theta
also seems to play a role in sensory-motor integration (Bland and Oddie, 2001).
Human theta oscillations occur during exploratory search and goal-seeking behaviors as well
as during virtual movement when sensory information and motor planning are both in flux but
not during periods of self-initiated stillness (Caplan et al. 2003). Movement-related theta
oscillations are observed in human hippocampus and cortex, suggesting that both structures
play a role in sensorimotor integration (Ekstrom et al., 2005). This suggests that experimental
data regarding Aβ-induced hippocampal theta rhythm alterations in rats is important in
understanding sensorimotor processing in human patients suffering from AD.
In vitro, medial septal neurons have been classified according to their firing patterns and
membrane properties as slow-firing, fast-firing, regular-firing or burst-firing (Jones et al.,
1999; Henderson et al., 2001; Garrido et al., in press). These electrophysiologically
characterized septal neurons have been identified in vitro using single cell reverse transcriptase
polymerase chain reaction (RT-PCR). While cholinergic neurons typically display slow-firing
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phenotypes, most GABAergic neurons display fast- and burst-firing phenotypes. In contrast,
glutamatergic neurons display heterogeneous firing properties, including slow-firing
phenotypes (Sotty et al., 2003; Manseau et al., 2005).
In animal models of AD, Aβ peptide 1–42 injections into the medial septum injured neurons.
Most neurons damaged by Aβ were choline acetyltransferase (ChAT) positive, while only
minor effects of Aβ were observed on parvalbumin (PV) positive neurons (putative
GABAergic) (Harkany et al., 1995). The effect of Aβ on glutamatergic septal neurons is not
known due largely to the fact that a significant septal glutamatergic neuronal population was
only recently described.
Glutamatergic actions in other regions of the brain show that glutamate mediates most
excitatory synaptic transmission in the brain. In addition, synaptic strength at glutamatergic
synapses shows a remarkable degree of use-dependent plasticity which may represent a
physiological correlate to learning and memory (McGee and Bredt, 2003). Septal glutamatergic
neurons are well posed to control hippocampal excitability and rhythmical activities (e.g., theta
rhythm) that promote synaptic plasticity. Cholinergic mechanisms modulate glutamatergic
synapses and, through this action, learning and memory formation (Jerusalinsky et al., 1997).
Glutamatergic neurons, together with basal forebrain cholinergic neurons, constitute the two
neuronal systems highly vulnerable to AD (Francis et al., 1999; Bell and Cuello, 2006). Aβ-
induced damage of septal glutamatergic neurons may play a central role in AD. While
glutamate actions in various areas of the brain are well characterized, little is known about
septal glutamatergic neurons and their alterations induced by age-related pathologies such as
AD. Therefore, to investigate the effects of amyloid, an indicator of AD, on all three septal
neuronal populations, septal networks and septohippocampal function, we administered single
injections of Aβ 1–40 into the medial septum. Subsequently, electrophysiological recordings
of hipopocampal theta rhythm and immunohistochemistry were used to assess anatomical and
electrophysiological alterations.
2. Materials and Methods
2.1 Animals
Adult male Sprague Dawley rats (n= 50; 250–350 g; Harlan) were housed and maintained on
a 12/12-h light/dark cycle and provided food and water ad libitum. All animal protocols used
in this study were in compliance with the National Institutes of Health Guide for the Care and
Use of Laboratory Animals and approved by the Institutional Animal Care and Use Committee
of UTB/TSC. All surgical procedures and perfusions were performed with a ketamine-based
anesthetic (ketamine: 42.8mg/ml, xylazine: 8.6 mg/ml and acepromazine: 1.4 mg/ml in saline;
1 ml/kg).
2.2 Aβ Septal Injections
Synthetic Aβ peptide 1–40 (Bachem Torrance, California) and Aβ peptide 40-1(Bachem
Torrance, California), a reverse peptide used as a control, were separately dissolved in 0.01 M
phosphate-buffered saline (PBS) at a concentration of 2 μg/μl and incubated at 37 °C for one
week before use as described by Gonzalo-Ruiz and Sanz (2002) to allow aggregation of fibrils.
Atomic force microscopy was used to verify that incubated Aβ 1–40 contained soluble
oligomers before injections (Figure 1A, B).
Anesthetized animals received a single injection into the medial septum by means of a
stereotaxic apparatus (coordinates: AP=0.5, L=.2, V=−6.5 from the dura) (Figure 1C). Four
microliters of Aβ 1–40, Aβ 40-1, or PBS were injected with a 10-μL Hamilton syringe and the
needle kept in place for fifteen minutes before withdrawing. Ten to 15 animals were prepared
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for each experimental group (Aβ 1–40, Aβ 40-1 and PBS). Animals were allowed a one week
recovery period in their original housing environment prior to acute electrophysiological
procedures.
2.3 Electrophysiology
Animals were initially anesthetized with Isoflurane (The Butler Company, Dublin, OH) while
a jugular cannula was inserted. Isoflurane was then discontinued and Urethane (Sigma-Aldrich,
St. Louis, MO), 0.8 g/ml was administered via the jugular cannula to maintain an appropriate
level of anesthesia during the remaining surgical and experimental procedures. The rats were
placed in a stereotaxic instrument (David Kopf Instruments, Tujunga, CA) with the plane
between bregma and lambda horizontally leveled. Body temperature was maintained at 37°C
with a self regulating heating pad (Fine Science Tools Inc., Foster City, CA). An uninsulated
silver wire (Sigma-Aldrich, St. Louis, MO) placed in the cortex, anterior to bregma served as
an indifferent electrode. Another insulated stainless steel wire for recording hippocampal field
activity was placed in the right dorsal hippocampal formation in the dentate molecular layer
(3.8 mm posterior to bregma, 2mm lateral to the midline and 2.5 mm ventral to the dural
surface). To show that theta amplitude was not due to the electrode position, the point of
maximum theta amplitude was found in each experiment as described in previous work (Bland
and Colom 1993; Bland et al. 1999). Medial septum diagonal band of Broca (MS-DBB)
recordings were made 0.5mm anterior to bregma, 0.0–0.5 mm lateral to the midline, and ventral
5.2–7.2 mm from the dural surface. Cells were recorded with glass microelectrodes (15–30
MΩ) filled with 0.5 M sodium acetate. Hippocampal and septal microelectrodes were carried
in independent microdrives, Electrode Manipulator Model 960 (David Kopf Instruments,
Tujunga, CA) and a CMA-12CC actuator (Newport Corporation, Irvine, CA), respectively.
2.4 Histology
Animals (n=35) were deeply anesthetized and perfused intracardially with 0.1 M phosphate-
based buffer saline (PBS) (pH 7.4) followed by a fixative solution containing 4%
paraformaldehyde and 0.1% glutaraldehyde in 0.1 M PBS. Brains were removed, post-fixed
in the same fixative solution overnight and then cryoprotected in 30% sucrose. Thirty μm slices
were cut using a cryostat. Only brains with confirmed medial septal injection sites were used
in this study. Free floating sections were stored at 4°C in well plates containing PBS until
processed for immunohistochemistry. Sections surrounding the injection site were mounted
and processed for Thioflavine S to confirm the presence of Aβ deposits (Figure 1D).
Trajectories of electrodes used in electrophysiological recordings of theta rhythm in the
hippocampus were confirmed with Cresyl violet staining. Only recordings from animals with
confirmed hippocampal electrode trajectories were included in this study (n=183).
2.5 Immunohistochemistry
Free floating immunohistochemistry was performed on Aβ 1–40 treated and control tissue
(Aβ 40-1 and PBS) in order to visualize neuronal populations in the medial septum. Briefly,
medial septal sections were incubated for 10 min in 0.3% H2O2 to inhibit endogenous
peroxidase activity. Non-specific staining was blocked by incubating tissue in 10% bovine
serum albumin (BSA) for 1 hour at room temperature. Sections were incubated overnight in
primary antibodies at room temperature. A mouse anti-NeuN antibody (1:1000, Chemicon)
which stains neuronal nuclei was used to reveal the overall number of neurons. GABAergic
and cholinergic neurons were visualized using a mouse anti-GAD67 antibody (1:1000,
Chemicon) and a goat anti-ChAT antibody (1:200, Chemicon), respectively. Glutamatergic
populations were revealed using a mouse anti-glutamate antibody (1:3000, Immunostar).
Glutamatergic terminals were visualized using guinea pig anti-VGLUT1 (1:2000) and anti-
VGLUT2 (1:4000) antibodies (Chemicon). Following primary antibody incubation, sections
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were incubated at room temperature for 2 hours in their respective biotinylated secondary
antibodies (1:200), NeuN labeling: goat anti-mouse (Vector), GABAergic labeling: goat anti-
mouse (Vector), cholinergic labeling: donkey anti-goat (Vector), glutamatergic labeling: goat
anti-mouse (Vector). Finally, sections were incubated in avidin-biotin complex (ABC, Vector)
for 1 hour. Neuronal populations were revealed using the chromogen 3-3′diaminobenzidine
(DAB, Vector). In each experiment some sections were incubated without the primary antibody
to determine staining specificity. Sections were mounted onto gelatin-coated slides, dehydrated
in graded ethanol, cleared in xylene and coverslipped for further analysis.
2.6 Digital Imaging and Quantification
Bright field images were captured using an Axiovert 200 microscope (Zeiss) equipped with an
Optronics CCD camera coupled to StereoInvestigator software (MBF BioScience). Contours
of the medial septal region were determined using the corresponding sections of the stereotaxic
atlas of the rat brain (Paxinos and Watson, 1998). The area of the contour and the number of
cells within each contour was determined using the meander scan function in
StereoInvestigator. Cell density was calculated by dividing the number of cells by the area of
the contour in which the cells were located. Glutamatergic terminals (VGLUT1 and VGLUT2)
were estimated using the optical fractionator probe in StereoInvestigator.
2.7 Data acquisition, analysis and firing pattern classification
Brain signals were displayed, digitized, and sampled at a frequency of 10 KHz with a 12-bit
DT-2839 A/D board and SciWorks 3.0 SP1 (DataWave Technologies, Longmont, CO), and
recorded for off-line analysis. Electroencephalographic (EEG) signals were amplified and
filtered on-line (low-pass at 100 Hz) using an AC/DC amplifier (3000 model, A-M Systems,
Inc., Carlsborg, WA). Cell recordings were amplified and filtered on-line (low-pass at 2000
Hz, high-pass at 500 Hz) using a NEURODATA IR-183A recording amplifier and a FLA-01
filter/amplifier (Cygnus Technology, Inc. Delaware Water Gap, PA). Hippocampal field
potentials and septal cell discharges were simultaneously recorded during four hippocampal
field conditions: (1) LIA only, (2) transition from LIA to theta, (3) theta only, and (4) transition
from theta to LIA. Stable cell recordings were made for an average of 30 min to insure that a
minimum of 5–10 30-second transitions were acquired for analysis. Each EEG was subjected
to a fast Fourier analysis, Clampfit 9.2 (Molecular Devices, CA), and classified as either theta
or LIA by the following criteria: (1) the theta rhythm functional state was defined as a
sinusoidal-like waveform with a peak frequency of 3–8 Hz and a small bandwidth, and (2) the
“LIA” functional state was defined as a large amplitude irregular activity with a broad
frequency band (0.5–25.0 Hz) (Leung et al. 1982). Analysis of cell recordings (30 sec) using
Clampfit 9.2 software (Molecular Devices) provided the mean, firing frequency (Hz), action
potential duration (ms), and amplitude (mV). Septal neurons were classified as either slow-
firing or fast-firing as described by previous studies (Brazhnik and Fox 1997, 1999; Sotty et
al. 2003, Colom et al. 2006). Septal units having a mean firing frequency < 12 Hz were
considered slow firing neurons and units having a mean firing frequency ≥ 12 Hz were
considered fast-firing neurons. Firing periodicity (rhythmicity) was examined using
autocorrelation analysis. Rhythmical units showed periodicity in their autocorrelations (Bland
and Colom 1993). Cross-correlograms were used to determine whether septal units and
hippocampal θ rhythm recordings were related (SciWorks 3.0 SP1 software).
2.8 Statistical analysis
Mean cell densities of each neuronal population were compared amongst Aβ1–40, Aβ 40-1
and PBS treated rats using a one-way analysis of variance (ANOVA). ANOVA analysis was
followed by Tukey’s post hoc analysis. Significant differences for all statistical testing were
defined by a p value of less than 0.05. Numerical data is represented as means and standard
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errors (S.E.M.). All statistical tests were performed using statistical analysis software (SPSS
14.0, SPSS, Inc., Chicago, Illinois).
Mean cell firing frequencies and hippocampal theta rhythm power spectrum values were
compared amongst the three groups (Aβ1–40, Aβ 40-1, and PBS) using the Kruskal-Wallis
test. To find if there was a statistically significant reduction in the numbers of recorded neurons
in the three groups, the Difference in Proportions Test for Two Independent Proportions was
used. Significant differences for all statistical testing were defined by a p value of less than
0.05. All statistical tests were performed using StatsDirect 2.6.6 statistical software.
3. Results
3.1 Histology
Aβ deposits were detectable at the injection site of Aβ 1–40 treated tissue as verified by
Thioflavine S staining (Figure 1) and Congo Red (not shown) while no amyloid deposits were
detectable in Aβ 40-1 and PBS treated tissue (not shown). Cells with glial morphology were
visible near the injection site in stained tissue of all experimental groups (Aβ 1–40, Aβ 40-1,
PBS). However, glia was visibly more extensive in Aβ 1–40 treated tissue (not shown). This
glial reaction is consistent with previous studies (Giovannelli, et al. 1995,Scali., et al. 1999).
3.2 Aβ 1–40 produces an overall reduction in septal neurons
Analysis of NeuN-positive neuronal cell density in all groups revealed a significant decrease
in NeuN positive neurons in Aβ 1–40 treated tissue (28%, p= 0.021) compared to control groups
(PBS treated tissue), indicating an overall reduction of septal neurons (Figures 2, 3A–C). There
was no significant difference between the cell densities of PBS treated tissue and tissue treated
with Aβ 40-1 (Table 1).
3.3 Aβ 1–40 selectively injures cholinergic and glutamatergic septal neurons
Cholinergic neuronal density assessed by ChAT staining of somas was significantly reduced
by 57% compared to PBS controls (p=.001) (Table 1, Figures 2, 3D–F). Additionally,
glutamatergic neuronal density assessed by glutamate staining was significantly decreased by
53% compared to controls (p=.001) (Table 1, Figures 2, 3G–L). In contrast, populations of
GABAergic neurons assessed by GAD67 immunoreactivity were not significantly reduced
(Table 1). Thus, Aβ 1–40 selectively injures cholinergic and glutamatergic medial septal
neurons while sparing medial septum GABAergic neurons. No significant differences were
found between PBS and Aβ 40-1in these neuronal populations (Table 1).
3.4 Aβ 1–40 significantly reduces glutamatergic terminals in the medial septum
Glutamatergic terminals assessed by VGLUT1 and VGLUT2 punctate immunoreactivity were
significantly reduced following Aβ 1–40 injections into the medial septal region (Figures 4–
5). VGLUT1 terminals were reduced by 21% compared to PBS controls (p=.001) (Figures 4,
5A–C). VGLUT 2 terminals were reduced by 40% compared to PBS controls (p=.001) (Figures
4, 5D–F). In control tissue, the density of VGLUT 2 immunoreactive punctate was significantly
more abundant than VGLUT1 punctate which is in agreement with previous studies (Hajszan
et al, 2004). While both VGLUT1 and VGLUT2 puncta were reduced in Aβ 1–40 tissue,
VGLUT2 terminals in the medial septum were more affected than VGLUT1 terminals.
3.5 Aβ 1–40 altered the firing pattern of slow firing neurons
The mean firing rate of slow firing septal neurons was significantly higher in Aβ 1–40 treated
animals when compared to PBS and Aβ 40-1 control animals (Fig. 6A). In Aβ 1–40 treated
animals, slow firing neurons fired at a 55% and 46% higher rate during θ rhythm and LIA,
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respectively, compared to controls. There was no significant difference between the mean firing
rates of the PBS treated animals and the Aβ 40-1 treated animals (Figure 6, Table 2)
Accumulative data is depicted in fig 6B.
3.6 Hippocampal theta rhythm is abnormal in the Aβ 1–40 treated rat
Power Spectrum analysis from the EEG recordings in the hippocampus of the three
experimental groups showed that theta rhythm amplitude at peak frequency was altered in the
Aβ 1–40 treated group. Theta rhythm amplitude was reduced 49% (54592 mV2/Hz and 48989
mV2/Hz in controls to 26514 mV2/Hz in Aβ 1–40 treated animals, p = 0.001; Figure 6C–D)
compared to controls. No significant difference in power amplitude was found between PBS
and Aβ 40-1 controls.
3.7 Aβ 1–40 reduced the proportion of theta-correlated slow firing neurons
Examples of θ-correlated slow firing neurons from PBS, Aβ 40-1 and 1–40 are depicted in
figure 7A, B and C, respectively. The percentage of θ-correlated slow firing neurons was
significantly reduced by Aβ 1–40 septal injections. In the PBS and Aβ 40-1 treated groups, the
percentage of recorded θ-correlated slow firing neurons was 35.6% (21/59) and 33.7% (16/49),
respectively. In the Aβ 1–40 treated group, the percentage of recorded θ-correlated slow firing
neurons was 04.0% (2/51). In comparison to controls, there was a significant reduction in the
number of recorded θ-correlated slow firing neurons recorded in the Aβ 1–40 treated group (p
=1 0.001)(Figure 7D). For all three experimental groups, no statistical differences were found
in the fast firing group.
4. Discussion
The septo-hippocampal system is heavily affected in AD (Colom, 2006). Although Aβ is
implicated in AD neurodegenerative processes, little is known about how it affects the function
of specific septo-hippocampal networks. Furthermore, there are no studies correlating septo-
hippocampal anatomical and functional alterations in AD or animal models of AD.
While Aβ has been extensively used in vitro as a neurotoxin (Colom et al., 1998, Butterfield,
2002, Chen, 2005, Jarvis et al., 2007, Liao et al., 2007), comparative few in vivo studies have
been performed (Giovanelli et al., 1995; Gonzalo-Ruiz et al., 2003; Gonzalo-Ruiz et al.,
2006; Gonzales et al., 2007). Aβ has been applied in vivo using: (a) intraventricular injections
and (b) local injections into defined brain structures. While the first approach has been used to
study general effects (Nakamura et al., 2001), the second has primarily been used to determine
Aβ effects on specific neuronal populations (Giovanelli et al., 1995; Gonzalo-Ruiz et al.,
2003; Gonzalo-Ruiz et al., 2006; Gonzales et al., 2007). Since the primary goal of this study
was to investigate Aβ affects on a specific region of the basal forebrain, local injections of
Aβ were utilized.
Our data demonstrates that local injections of Aβ into the medial septum damage both
cholinergic and glutamatergic septal neuronal populations while sparing GABAergic neuronal
populations. The use of an antibody against the structural protein NeuN confirms that the
decrease in cholinergic and glutamatergic markers is due to a reduction in the population of
septal neurons and not transitory injuries. Thus, our animal model mimics the pathology
observed in humans with AD. While the vulnerability of cholinergic neurons to AD and Aβ
has been extensively documented (Davies, 1976), the vulnerability of glutamatergic systems
has only recently begun to be investigated (Francis et al., 1999). Our data show that septal
glutamatergic neurons are affected by Aβ. Our data also show that septal glutamatergic
terminals (VGLUT2) and glutamatergic terminals with an extraseptal origin (VGLUT1) are
affected by Aβ. Thus, the septal glutamatergic system and the circuits its neurons integrate are
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highly vulnerable to Aβ. This Aβ-induced glutamatergic damage in addition to the Aβ induced
cholinergic lesion may account for the septo-hippocampal physiological alterations observed
in our analysis of Aβ actions.
Aβ altered septal networks and produced a change in hippocampal theta rhythm. Recordings
of hippocampal theta rhythm in Aβ 1–40 treated rats displayed a significantly lower power/
amplitude (49% reduction) when compared to recordings from rats injected with PBS and
Aβ 40-1. The decrease in hippocampal theta amplitude suggests that the septal networks
necessary for theta rhythm production and maintenance are altered by Aβ 1–40 injections in
the medial-septum of rats. This reduction in the theta rhythm amplitude may be a consequence
of the reduction in the number of theta-correlated slow firing septal neurons in the septo-
hippocampal networks.
The occurrence of hippocampal theta rhythm is dependent upon the proportion of septal
neurons involved in the rhythmic process. Furthermore, the frequency of the theta field activity
is determined by the frequency of the rhythmical “theta” bursts in septal neurons (Bland and
Colom, 1993; Vinogradova, 1995). Septal lesions abolish the hippocampal theta rhythm in
rodents, providing further evidence of the importance of the septum in theta generation
(Andersen et al., 1979; Rawlins et al., 1979; Winson, 1978). Thus, a reduction of septal
cholinergic (57%) and glutamatergic (53%) neuronal populations plus a reduction of
glutamatergic terminals (VGLUT1: 21%, VGLUT2: 40%) is sufficient to significantly alter
the amplitude of hippocampal theta rhythm as well as the hippocampal functions that require
neuronal synchronization at theta frequencies.
One possible reason for this alteration is that Aβ septal injections are acting at the hippocampal
level through a reduction of acetylcholine release (Abe et al., 1994). The diminished amount
of acetylcholine may not be sufficient to appropriately synchronize hippocampal networks.
Reduced septal glutamatergic influences most likely add to this effect. Theta frequency and
amplitude are affected by lateral septum modulation of NMDA receptors (Puma et al., 1996;
Puma and Bizot, 1999, Bland et al., 2007). Furthermore, the injection of NMDA receptor
antagonists into the MS-DB significantly decreases hippocampal theta rhythm amplitude
(Leung and Shen, 2004). Puma’s and Leung’s results in conjunction with our findings suggest
that septal glutamatergic synapses play an important role in hippocampal theta rhythm
generation. Deficit in glutamatergic synaptic transmission and synchronous network activity
have been found in hippocampal slices from transgenic mice over expressing the human form
of the amyloid precursor protein (APP) harboring the Swedish mutation (Brown et al., 2005),
suggesting that Aβ increases may lead to dysfunctional glutamatergic systems. In the medial
septum bath application of Aβ (1–40 and 25–35) also depressed glutamatergic synaptic
transmission (Santos-Torres et al., 2007).
In contrast to the amplitude/power changes observed, the theta frequency was unchanged in
recordings from Aβ-treated rats compared to control rats. This finding suggests that the
surviving neurons and circuits are adequate to maintain oscillatory activities at theta
frequencies and that basic generator mechanisms continue operating at the same pace in Aβ-
treated rats. The exact mechanism underlying theta oscillations is still under debate (Colom,
2006). In Aβ treated animals, oscillations at theta frequencies may be produced by (a) surviving
neurons of Aβ-altered septal circuits, (b) unaffected extra-septal networks or (c) both (Bland
and Colom, 1993; Colom, 2006). Our data suggest that Aβ-induced reductions in theta power
may be produced by the reduction in rhythmically firing septal neurons. Bassant’s group
(Simon et al., 2006) did not find septal cholinergic neurons correlated to the hippocampal theta
rhythm in anesthetized and non-anesthetized in vivo preparations. Their work suggests that
most rhythmical septal neurons are GABAergic or glutamatergic. Reduction of septal
cholinergic and glutamatergic inputs onto GABAergic septal neurons may reduce the
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population of rhythmically bursting GABAergic neurons. Although unaffected in numbers,
the population of septal GABAergic neurons may be dysfunctional in Aβ-treated animals.
Juxtacellular or intracellular recordings with identification of neuronal phenotypes are needed
to clarify this issue.
At the unitary level slow firing neurons from Aβ-treated animals significantly increased their
firing rates. This finding suggests that: (a) surviving slow firing neurons must increase their
activity to support a reduced amplitude theta or (b) increased firing patterns are a direct result
of Aβ-induced toxicity. Discerning between these two possibilities exceeds the scope of this
study and will be the aim of future investigations in our laboratory. Slow firing septal
cholinergic neurons have typically been considered important for theta generation (Yoder and
Pang, 2005; Colom, 2006). This study shows that altered hippocampal theta is associated with
altered slow firing patterns in septal neurons. Slow firing septal neurons, most likely
cholinergic and glutamatergic (Sotty et al., 2003; Manseau et al., 2005), may provide a
background of excitation for theta rhythm generation. This activity may be increased in the
Aβ-injured brain to compensate for the septal neuronal loss. Thus, our data further supports
the notion that slow firing septal neurons play a role in hippocampal theta rhythm generation.
Preliminary experiments not reported in this study using anti-VGLUT1 and anti-VGLUT2
antibodies in colchicine-treated rats revealed that VGLUT2 neurons constitute a larger
neuronal population in the medial septum when compared to VGLUT1 neurons. Thus,
numerous VGLUT2 terminals in the medial septum may originate from intraseptal VGLUT2
neurons, while VGLUT1 terminals might represent extraseptal VGLUT1 projections. These
results suggest that reductions in VGLUT2 puncta may correspond to reductions in septal
glutamate-immunoreactive neurons but reductions in VGLUT1 puncta represent lesions of
septal terminals that originate in extraseptal glutamatergic populations. Thus, Aβ may injure
both local circuits and circuits with extraseptal components.
Excitotoxic mechanisms have been implicated in cell death in AD (Gray and Patel, 1995). This
is further supported by the neuroprotective effect of the NMDA antagonist memantine (Hynd
et al., 2004) in AD patients. The finding that glutamatergic septal neurons are susceptible to
Aβ may indicate that Aβ affects the septum through excitotoxic mechanisms. The presence of
functional NMDA receptors in septal neurons (Kumamoto and Murata, 1995) suggests that the
machinery needed for excitotoxic processes is present in the septum. Some of the slow firing
neurons recorded in this study were probably glutamatergic (Sotty et al., 2003; Manseau et
al., 2005). Slow firing neurons showed increased firing rates following Aβ 1–40 treatment.
Those alterations may be part of a process that leads to increases in glutamate release and
excessive activation of NMDA receptors in Aβ-treated rats. This mechanism may lead to
neurodegeneration and explain the reduction in slow firing neuronal numbers in our
electrophysiological recordings as well as the reduced number of cholinergic and glutamatergic
neurons in our anatomical experiments. Further studies are necessary to determine the
mechanisms underlying Aβ-induced septal functional alterations and neuronal degeneration.
In conclusion, this study shows that cholinergic and glutamatergic septal neurons are
vulnerable to Aβ and that glutamatergic circuits are injured in the presence of amyloid. This
alteration in septal neuronal populations and circuitry results in abnormal hippocampal theta
rhythms suggesting that these neurons and circuits are important in maintaining the amplitude
of septo-hippocampal rhythmic activities at theta frequencies.
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A–B. Atomic force microscope (AFM) measurements showed minimum oligomerization in
non-aged Aβ samples (A) and the presence of abundant oligomers in aged samples of Aβ 1–
40 (B). C. Diagram depicting medial septum injection site. D. Fluorescent image of Thioflavine
S in medial septum verifying presence of Aβ 1–40. Insert shows a magnified image of the
injection, illustrating that Aβ is isolated to the medial septum. Only injections with minimal
diffusion to adjacent areas were used.
Colom et al. Page 13














Graph comparing the mean cell density of overall (NeuN), cholinergic (ChAT), glutamatergic
(Gluta) and GABAergic (GABA) populations in the medial septum of PBS control rats, Aβ
(40-1) control rats and Aβ 1–40 treated rats. Aβ 1–40 significantly reduced the overall number
of medial septal neurons labeled by NeuN (F[2,20]=4.69, p=0.02. While the numbers of both
cholinergic (F[2,32] =11.2, p<0.01) and glutamatergic (F[2,32]=2.32, p<0.01) neurons were
significantly reduced GABAergic neurons were resistant to Aβ 1–40 (p>0.55). PBS or the
reverse peptide did not produce significant alterations. *Statistically significant, P<0.05.
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Photomicrographs of NeuN (A–C), ChAT (D–F) and glutamate (G–I) immunoreactive neurons
in the medial septum of PBS (A,D,G), Aβ 40-1 (B,E,H) and Aβ 1–40 (C,F,I) treated rats. Note
the reduction in neuronal density in Aβ 1–40 treated tissue compared to control tissue. Panels
J–L illustrate the reduction in glutamatergic cell density in PBS (J), Aβ 40-1 (K) and Aβ 1–40
(L) treated rats. Scale bar = 50 μm.
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Graph comparing the mean density of VGLUT1 and VGLUT2 puncta in the medial septum of
PBS control rats (n=10), Aβ (40-1) control rats (n=6) and Aβ treated rats (n=10). In Aβ 40-1
treated tissue, terminal density in both VGLUT1 (F[2,23] =52.5, p<0.01) and VGLUT2
(F[2,32] =128.4, p<0.01) was significantly reduced. *Statistically significant, p<0.05.
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Photomicrograph of VGLUT1 (A–C) and VGLUT2 (D–F) immunoreactive puncta in the
medial septum of PBS (A, D), Aβ 40-1 (B, E) (n=6) and Aβ 1–40 (C, F) treated rats (n=10).
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A. Comparison of hippocampal field potentials (top trace) and firing patterns (bottom trace)
of slow firing neurons (unit) from PBS, Aβ 40-1, and Aβ 1–40 treated animals. B. Bar graph
depicting a significant increase in mean firing rates of slow firing neurons in Aβ 1–40 treated
animals compared to controls. C. Graph of power spectrum of θ frequencies versus θ frequency
of individual neurons illustrating that tail pinch induced robust field potential oscillations in
controls but lowered the θ amplitude in Aβ 1–40 treated animals. D. Graph indicating power
spectrum of recorded θ field potentials from Aβ 1–40 treated animals is significantly less than
that of control. *Statistically significant, p<0.05.
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A–C. Slow firing unit recordings (second trace) during θ and LIA episodes. Time histograms
show neurons cross-correlated and auto-correlated with hippocampal field potentials during
θ and LIA. D. Bar graph comparing non θ–correlated and θ–correlated slow firing neurons in
Aβ 1–40, PBS and Aβ 40-1 treated groups. Slow firing neurons correlated with hippocampal
θ rhythm decreased by 96.0% after septal injections of Aβ 1–40. In the PBS and Aβ 40-1 treated
groups, recordings of slow firing neurons correlated to hippocampal θ rhythm were 35.6% and
33.7%, respectively. Compared to controls, there was a significant reduction in the number of
slow firing neurons correlated to hippocampal theta rhythm in the Aβ 1–40 treated group.
*Statistically significant, p<0.05.
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Table 1
Mean cell densities of neuronal populations within the MS of PBS control rats, Aβ 40-1 control rats and Aβ
1–40 treated rats using ANOVA.
Phenotype PBS (cell/mm2) Aβ 40-1 (cell/mm2) Aβ 1–40 (cell/mm2)
NeuN* (n = 5) 1261.8 ± 164.1 (n = 6) 1240.5 ± 137.7 (n = 12) 910.1 ± 48.5
ChAT* (n = 11) 287.9 ± 47.7 (n = 6) 246.3 ± 24.1 (n = 18) 122.4 ± 9.2
GAD67 (n = 11) 273.5 ± 29.3 (n = 6) 248.5 ± 23.0 (n = 17) 232.2 ± 26.1
Gluta* (n = 11) 770.3 ± 64.1 (n = 6) 710.2 ± 42.0 (n = 18) 362.7 ± 31.0
*
Statistically significant, p<0.05.
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Table 2
Mean firing rates of different neuronal firing patterns during Θ rhythm and LIA.
PBS (n=69) (spikes/sec)
Aβ 40-1 (n=53) (spikes/
sec)
Aβ 1–40 (n=61) (spikes/
sec)
Slow firing
 Θ Correlated k = 21 k = 16 k = 2
  Firing rate at Θ* 2.90 ± 0.54 4.03 ± 0.64 5.00 ± 0.80
  Firing rate at LIA* 2.57 ± 0.63 2.04 ± 0.42 1.00 ± 0.40
 Non Θ Correlated k = 38 k = 33 k = 49
  Firing rate at Θ* 1.15 ± 0.32 1.58 ± 0.39 3.93 ± 0.46
  Firing rate at LIA* 1.61 ± 0.42 1.41 ± 0.53 3.55 ± 0.42
Fast Firing
 Θ Correlated k = 4 k = 1 k = 2
  Firing rate at Θ 19.55 ± 3.31 21.20 19.00 ± 3.80
  Firing rate at LIA 11.35 ± 2.00 4.80 15.80 ± 9.80
 Non Θ Correlated k = 6 k = 3 k = 8
  Firing rate at Θ 19.66 ± 2.46 29.27 ± 7.62 19.11 ± 2.41
  Firing rate at LIA 15.87 ± 3.85 20.73 ± 5.39 18.97 ± 5.36
*
Statistically significant, p<0.05.
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